This provider's $22.7M in total Medicare payments ranks in the 96th percentile of Clinical Laboratory providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 1224% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2021 | $1.6K | $551.48 | 2.96x | $1.1K | $13.4M | 24.3K | 20 |
| 2022 | $1.2K | $323.18 | 3.63x | $851.12 | $655.4K | 2.0K | 6 |
| 2023 | $25.00 | $11.76 | 2.13x | $13.24 | $8.7M | 738.2K | 1 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 738.2K | $8.7M | $11.76 | 2.13x |
| 81408 | Molecular pathology procedure level 9 | 3.2K | $6.4M | $2.0K | 2.00x |
| 81404 | Molecular pathology procedure level 5 | 9.0K | $2.5M | $274.83 | 3.97x |
| 81407 | Molecular pathology procedure level 8 | 1.6K | $1.3M | $846.27 | 3.84x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 1.8K | $1.1M | $600.00 | 4.00x |
| 81405 | Molecular pathology procedure level 6 genetic analysis | 3.6K | $1.1M | $301.35 | 3.32x |
| 81406 | Molecular pathology procedure level 7 | 2.9K | $827.1K | $282.88 | 4.00x |
| 81403 | Molecular pathology procedure level 4 | 3.5K | $652.3K | $185.20 | 4.00x |
| 81223 | Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence | 34 | $17.0K | $499.00 | 2.00x |
| 81325 | Gene analysis (peripheral myelin protein 22), full sequence analysis | 22 | $16.9K | $769.58 | 2.00x |
| 81435 | Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes | 26 | $15.2K | $584.90 | 2.00x |
| 81306 | Gene analysis (nudix hydrolase 15) for common variants | 50 | $14.6K | $291.36 | 2.00x |
| 81226 | Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants | 24 | $10.8K | $450.91 | 2.00x |
| 81432 | Test for detecting genes associated with inherited breast cancer-related disorders | 15 | $10.2K | $679.05 | 2.00x |
| 81225 | Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants | 29 | $8.4K | $291.36 | 2.00x |
| 81401 | Molecular pathology procedure level 2 | 61 | $8.4K | $137.00 | 2.00x |
| 81335 | Gene analysis (thiopurine s-methyltransferase) for common variant | 47 | $8.2K | $174.81 | 2.00x |
| 81232 | Gene analysis (dihydropyrimidine dehydrogenase) for common variant | 45 | $7.9K | $174.81 | 2.00x |
| 81227 | Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants | 44 | $7.7K | $174.81 | 2.00x |
| 81230 | Gene analysis (cytochrome p450 family 3 subfamily a member 4) for common variant | 44 | $7.7K | $174.81 | 2.00x |
This provider submits charges 2.66 times higher than what Medicare actually pays.
A markup ratio of 2.66x means for every $100 Medicare pays, this provider initially charges $266. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in TX for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Clinical Pathology Laboratories, Inc. | Austin, TX | $541.0M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Irving, TX | $453.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Dallas, TX | $389.6M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Houston, TX | $311.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Houston, TX | $299.4M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data